IBIO logo

IBio (IBIO) Cash From Investing

Annual CFI

$906.00 K
-$6.10 M-87.07%

June 30, 2024

Summary

Performance

1-Year Change

-87.07%

3-Year Change

+103.42%

5-Year Change

+191.52%

15-Year Change

+156.87%

IBIO Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

70.44%
IBIO annual cash flow from investing activities is higher than 70.44% of companies in Healthcare sector

High & Low

All-time High

$7.01 M
IBIO annual cash flow from investing activities is currently -87.07% below its historical high of $7.01 million

3-Year Low

-$26.48 M

Earnings dates

Last Annual Earnings Report Date

Jun 30, 2024
IBIO previous annual earnings announcement was published on Jun 30, 2024

Next Annual Earnings Report Date

N/A
IBIO next annual earnings announcement has not yet been scheduled

OtherIBIOcash flowmetrics:

Annual CFF

$24.49 M
IBIO annual cash flow from financing activities is $24.49 million

Annual CFO

-$18.55 M
IBIO annual cash flow from operations is -$18.55 million

Annual FCF

-$18.76 M
IBIO annual free cash flow is -$18.76 million

Annual CAPEX

$210.00 K
IBIO annual capital expenditures is $210.00 thousand

Quarterly CFI

$713.00 K
+$857.00 K+595.14%

September 30, 2024

Summary

Performance

3-Month Change

+595.14%

1-Year Change

+595.14%

3-Year Change

-91.35%

5-Year Change

-91.35%

IBIO Quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

73.93%
IBIO quarterly cash flow from investing activities is higher than 73.93% of companies in Healthcare sector

High & Low

All-time High

$8.24 M
IBIO quarterly cash flow from investing activities is currently -91.35% below its historical high of $8.24 million

3-Year Low

-$1.25 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
IBIO previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

N/A
IBIO next earnings announcement has not yet been scheduled

OtherIBIOcash flowmetrics:

Quarterly CFF

-$162.00 K
IBIO quarterly cash flow from financing activities is -$162.00 thousand

Quarterly CFO

-$3.71 M
IBIO quarterly cash flow from operations is -$3.71 million

Quarterly FCF

-$3.71 M
IBIO quarterly free cash flow is -$3.71 million

Quarterly CAPEX

-
IBIO quarterly capital expenditures value is unknown

TTM CFI

$1.57 M
+$663.00 K+73.18%

September 30, 2024

Summary

Performance

3-Month Change

+73.18%

1-Year Change

+73.18%

3-Year Change

-79.06%

5-Year Change

-79.06%

IBIO TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

73.48%
IBIO TTM cash flow from investing activities is higher than 73.48% of companies in Healthcare sector

High & Low

All-time High

$8.29 M
IBIO TTM cash flow from investing activities is currently -81.06% below its historical high of $8.29 million

3-Year Low

-$13.04 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
IBIO previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

N/A
IBIO next earnings announcement has not yet been scheduled

OtherIBIOcash flowmetrics:

TTM CFF

$21.86 M
IBIO TTM cash flow from financing activities is $21.86 million

TTM CFO

-$16.93 M
IBIO TTM cash flow from operations is -$16.93 million

TTM FCF

-$16.93 M
IBIO TTM free cash flow is -$16.93 million

TTM CAPEX

-
IBIO TTM capital expenditures value is unknown

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

IBIO Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-87.1%+595.1%+73.2%
3 y3 years+103.4%-91.3%-79.1%
5 y5 years+191.5%-91.3%-79.1%

IBIO Cash From Investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-87.1%+103.4%-91.3%+156.8%-81.1%+112.0%
5 y5-year-87.1%+103.4%-91.3%+105.5%-81.1%+105.9%
alltimeall time-87.1%+103.4%-91.3%+105.5%-81.1%+105.9%

IBio Cash From Investing History

DateAnnualQuarterlyTTM
Sep 2024
-
$713.00 K(-595.1%)
$1.57 M(+73.2%)
Jun 2024
$906.00 K(-87.1%)
-$144.00 K(-114.4%)
$906.00 K(-13.2%)
Mar 2024
-
$1.00 M(>+9900.0%)
$1.04 M(-87.4%)
Dec 2023
-
$0.00(-100.0%)
$8.29 M(+17.9%)
Sep 2023
-
$50.00 K(-933.3%)
$7.03 M(+0.3%)
Jun 2023
$7.01 M(-236.7%)
-$6000.00(-100.1%)
$7.01 M(-6.4%)
Mar 2023
-
$8.24 M(-756.7%)
$7.49 M(-3329.3%)
Dec 2022
-
-$1.25 M(-4427.6%)
-$232.00 K(-554.9%)
Sep 2022
-
$29.00 K(-93.9%)
$51.00 K(-101.0%)
Jun 2022
-$5.13 M(-80.6%)
$477.00 K(-7.7%)
-$5.13 M(-39.8%)
Mar 2022
-
$517.00 K(-153.2%)
-$8.51 M(-34.7%)
Dec 2021
-
-$972.00 K(-81.1%)
-$13.04 M(-47.9%)
Sep 2021
-
-$5.15 M(+77.1%)
-$25.03 M(-5.5%)
Jun 2021
-$26.48 M(+2194.5%)
-$2.91 M(-27.6%)
-$26.48 M(+8.6%)
Mar 2021
-
-$4.01 M(-69.0%)
-$24.39 M(+19.1%)
Dec 2020
-
-$12.96 M(+96.3%)
-$20.47 M(+165.0%)
Sep 2020
-
-$6.60 M(+704.9%)
-$7.72 M(+569.3%)
Jun 2020
-$1.15 M(+16.6%)
-$820.00 K(+754.2%)
-$1.15 M(+127.6%)
Mar 2020
-
-$96.00 K(-53.8%)
-$507.00 K(-7.8%)
Dec 2019
-
-$208.00 K(+593.3%)
-$550.00 K(-24.8%)
Sep 2019
-
-$30.00 K(-82.7%)
-$731.00 K(-26.2%)
Jun 2019
-$990.00 K(-8.2%)
-$173.00 K(+24.5%)
-$990.00 K(-9.9%)
Mar 2019
-
-$139.00 K(-64.3%)
-$1.10 M(-23.9%)
Dec 2018
-
-$389.00 K(+34.6%)
-$1.45 M(+15.0%)
Sep 2018
-
-$289.00 K(+2.5%)
-$1.26 M(+16.5%)
Jun 2018
-$1.08 M(-32.3%)
-$282.00 K(-41.9%)
-$1.08 M(-18.4%)
Mar 2018
-
-$485.00 K(+141.3%)
-$1.32 M(+16.0%)
Dec 2017
-
-$201.00 K(+81.1%)
-$1.14 M(+3.4%)
Sep 2017
-
-$111.00 K(-78.9%)
-$1.10 M(-30.8%)
Jun 2017
-$1.59 M(+2242.6%)
-$525.00 K(+73.3%)
-$1.59 M(+41.2%)
Mar 2017
-
-$303.00 K(+85.9%)
-$1.13 M(+36.2%)
Dec 2016
-
-$163.00 K(-72.9%)
-$828.00 K(+27.0%)
Sep 2016
-
-$602.00 K(+903.3%)
-$652.00 K(+858.8%)
Jun 2016
-$68.00 K
-$60.00 K(+1900.0%)
-$68.00 K(-4.2%)
Mar 2016
-
-$3000.00(-123.1%)
-$71.00 K(-40.8%)
DateAnnualQuarterlyTTM
Dec 2015
-
$13.00 K(-172.2%)
-$120.00 K(-40.6%)
Sep 2015
-
-$18.00 K(-71.4%)
-$202.00 K(-6.0%)
Jun 2015
-$215.00 K(-17.0%)
-$63.00 K(+21.2%)
-$215.00 K(+1.9%)
Mar 2015
-
-$52.00 K(-24.6%)
-$211.00 K(-23.8%)
Dec 2014
-
-$69.00 K(+122.6%)
-$277.00 K(+19.9%)
Sep 2014
-
-$31.00 K(-47.5%)
-$231.00 K(-10.8%)
Jun 2014
-$259.00 K(+32.8%)
-$59.00 K(-50.0%)
-$259.00 K(+9.3%)
Mar 2014
-
-$118.00 K(+413.0%)
-$237.00 K(+42.8%)
Dec 2013
-
-$23.00 K(-61.0%)
-$166.00 K(-15.3%)
Sep 2013
-
-$59.00 K(+59.5%)
-$196.00 K(+0.5%)
Jun 2013
-$195.00 K(-20.4%)
-$37.00 K(-21.3%)
-$195.00 K(-10.3%)
Mar 2013
-
-$47.00 K(-11.3%)
-$217.40 K(-7.1%)
Dec 2012
-
-$53.00 K(-8.6%)
-$233.90 K(+11.1%)
Sep 2012
-
-$58.00 K(-2.4%)
-$210.60 K(-14.0%)
Jun 2012
-$245.00 K(+160.4%)
-$59.40 K(-6.5%)
-$244.90 K(+206.9%)
Mar 2012
-
-$63.50 K(+113.8%)
-$79.80 K(+13.2%)
Dec 2011
-
-$29.70 K(-67.8%)
-$70.50 K(-39.5%)
Sep 2011
-
-$92.30 K(-187.3%)
-$116.50 K(+23.8%)
Jun 2011
-$94.10 K(-83.7%)
$105.70 K(-295.0%)
-$94.10 K(-64.7%)
Mar 2011
-
-$54.20 K(-28.4%)
-$266.40 K(-28.8%)
Dec 2010
-
-$75.70 K(+8.3%)
-$374.20 K(-14.4%)
Sep 2010
-
-$69.90 K(+5.0%)
-$437.00 K(-24.3%)
Jun 2010
-$577.00 K(-64.3%)
-$66.60 K(-58.9%)
-$577.00 K(-16.6%)
Mar 2010
-
-$162.00 K(+17.0%)
-$691.90 K(+18.4%)
Dec 2009
-
-$138.50 K(-34.0%)
-$584.30 K(-38.1%)
Sep 2009
-
-$209.90 K(+15.6%)
-$943.40 K(-41.7%)
Jun 2009
-$1.62 M(+462.0%)
-$181.50 K(+233.6%)
-$1.62 M(+6.3%)
Mar 2009
-
-$54.40 K(-89.1%)
-$1.52 M(-6.3%)
Dec 2008
-
-$497.60 K(-43.7%)
-$1.62 M(+42.0%)
Sep 2008
-
-$883.90 K(+939.9%)
-$1.14 M(+297.2%)
Jun 2008
-$287.80 K(-72.9%)
-$85.00 K(-45.5%)
-$287.70 K(+41.9%)
Mar 2008
-
-$155.90 K(+770.9%)
-$202.70 K(+333.1%)
Dec 2007
-
-$17.90 K(-38.1%)
-$46.80 K(+61.9%)
Sep 2007
-
-$28.90 K
-$28.90 K
Jun 2007
-$1.06 M
-
-

FAQ

  • What is iBio annual cash flow from investing activities?
  • What is the all time high annual CFI for iBio?
  • What is iBio annual CFI year-on-year change?
  • What is iBio quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for iBio?
  • What is iBio quarterly CFI year-on-year change?
  • What is iBio TTM cash flow from investing activities?
  • What is the all time high TTM CFI for iBio?
  • What is iBio TTM CFI year-on-year change?

What is iBio annual cash flow from investing activities?

The current annual CFI of IBIO is $906.00 K

What is the all time high annual CFI for iBio?

iBio all-time high annual cash flow from investing activities is $7.01 M

What is iBio annual CFI year-on-year change?

Over the past year, IBIO annual cash flow from investing activities has changed by -$6.10 M (-87.07%)

What is iBio quarterly cash flow from investing activities?

The current quarterly CFI of IBIO is $713.00 K

What is the all time high quarterly CFI for iBio?

iBio all-time high quarterly cash flow from investing activities is $8.24 M

What is iBio quarterly CFI year-on-year change?

Over the past year, IBIO quarterly cash flow from investing activities has changed by +$857.00 K (+595.14%)

What is iBio TTM cash flow from investing activities?

The current TTM CFI of IBIO is $1.57 M

What is the all time high TTM CFI for iBio?

iBio all-time high TTM cash flow from investing activities is $8.29 M

What is iBio TTM CFI year-on-year change?

Over the past year, IBIO TTM cash flow from investing activities has changed by +$663.00 K (+73.18%)